Tumor necrosis factor expression in human epithelial tumor cell lines

Area of Science:

• Oncology
• Immunology
• Molecular Biology

Background:

• Tumor necrosis factor (TNF) is a cytokine with known anti-tumor properties.
• The mechanisms underlying tumor cell resistance to TNF remain poorly understood.
• Understanding TNF resistance is crucial for developing effective cancer therapies.

Purpose of the Study:

• To investigate the basis of resistance to TNF in human epithelial tumor cell lines.
• To determine if resistant cells express TNF or its receptors.
• To explore the relationship between TNF expression and resistance.

Main Methods:

• Exposure of 14 epithelial tumor cell lines to varying concentrations of TNF.
• Analysis of cell surface TNF binding sites using radioligand binding assays.
• Detection of TNF mRNA levels via Northern blot analysis.
• Assessment of TNF transcript expression in the presence of cycloheximide.
• Characterization of TNF-like protein production in resistant cells.

Main Results:

• Eleven out of 14 epithelial tumor cell lines exhibited resistance to TNF's growth inhibitory effects.
• Most resistant cell lines possessed high-affinity TNF cell surface receptors, indicating resistance is not due to receptor absence.
• Three resistant cell lines expressed detectable TNF mRNA.
• Both sensitive and resistant cells could produce TNF transcripts when protein synthesis was inhibited.
• Resistant ovarian carcinoma cells (Ov-D) produced a TNF-like protein.

Conclusions:

• Human epithelial tumor cell lines resistant to TNF can inherently express this cytokine.
• TNF resistance may involve mechanisms beyond receptor availability, including intrinsic cytokine production.
• Further research is needed to elucidate the precise mechanisms of TNF resistance in cancer.